CSL Behring - Blood Disorder Treatment products (inc Haemophilia A & B)

View buyer

Estimated value

£416k

Awarded value

£416k

Awarded 01 Jan 2025

Suppliers

1

Lots

1

1 awarded

Published

12 Mar 2025

Deadline 31 Dec 2024

Description

Call off contract/order from the NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A & B. Offer reference number: CM/PHS/22/5661 Specifically for products: Anti D Beriplex Kybernin-P Voncento

Scope

Reference
CF-2914900D0O000000rwimUAA
Total value
£416,031.93 excluding VAT
Commercial tool
Standalone contract
Contract dates
01 Jan 2025 to 29 Apr 2027
CPV classifications
33600000

Submission & procedure

Submission deadline
31 Dec 2024, 12:00 pm

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£416k

Award date

01 Jan 2025

Contract start

01 Jan 2025

Contract end

29 Apr 2027